Martin Shkreli: Daraprim Has Always Been Affordable

0
Martin Shkreli: Daraprim Has Always Been Affordable
Screenshot from a Martin Shkreli Youtube video

Martin Shkreli: Daraprim Has Always Been Affordable
Published on Nov 25, 2015
Nov. 25 — Turing Pharmaceuticals LLC CEO Martin Shkreli discusses the pricing of the company’s pharmaceuticals. He speaks on “Bloomberg Markets.”

Odey’s Special Situations Fund highlights Formula One and Shaw

Crispin OdeyThe Odey Special Situations Fund was down 0.27% for April, compared to its benchmark, the MSCI World USD Index, which was up 4.65%. For the first four months of the year, the fund is up 8.4%, while its benchmark returned 9.8%. Q1 2021 hedge fund letters, conferences and more The Odey Special Situations Fund is Read More


No posts to display